Developability Evaluation & Optimizaiton Service for Veterinary (Pet) Antibody

Q: How does this service compare to just doing an in silico analysis on our own?

While in silico analysis is a powerful first step, it is predictive, not definitive. Our service provides critical value by validating computational predictions with rigorous, empirical biophysical and chemical stability data. This integration of computational and experimental results provides a much higher degree of confidence in your candidate selection and de-risking strategy.

Are you currently facing challenges with poor stability, unexpected immunogenicity, or difficult manufacturing of your veterinary antibody candidates? Creative Biolabs' antibody developability evaluation & optimization service helps you select and engineer superior antibody leads for companion animals. Through a suite of advanced in silico and high-throughput biophysical assays, we identify and mitigate risks early, ensuring a smoother, more cost-effective transition from discovery to development.

Introduction

Navigating the path to a successful veterinary biologic requires more than just high affinity. It demands a candidate with robust biophysical and chemical properties to ensure it can be manufactured at scale, remain stable in formulation, and exhibit predictable behavior in vivo. Creative Biolabs' service is designed to provide a comprehensive, data-driven assessment of your lead antibody candidates, specifically for companion animal applications. We deliver a clear verdict on their viability and provide actionable recommendations for optimization, mitigating the risk of costly late-stage failures. Our goal is to ensure that the candidate you advance into cell line development and preclinical studies has the highest possible chance of success.

Discover How We Can Help - Request a Consultation

Workflow

Our workflow is a systematic, multi-stage process designed for maximum clarity and efficiency. We integrate in silico analysis with empirical laboratory testing to build a complete profile of your veterinary antibody candidate.

Fig 1. Pet Therapeutic Antibody Developability Evaluation and Optimization Service Workflow. (Creative Biolabs Original)

Workflow	Description
In Silico & Sequence Liability Assessment	We perform a comprehensive computational analysis of the antibody sequence to identify potential liabilities. This includes screening for glycosylation sites, deamidation and oxidation motifs, and aggregation-prone regions using proprietary algorithms tuned for veterinary species. The expected outcome is a ranked list of potential risks based on sequence data.
Expression & Purification Confirmation	If starting from sequence, we perform small-scale transient expression in CHO or HEK293 cells and purify the antibody. This step confirms the molecule can be produced and provides the necessary material for subsequent assays.
Biophysical Characterization	We assess the antibody's core physical properties. This stage involves techniques like Dynamic Light Scattering (DLS) to measure aggregation propensity, Differential Scanning Fluorimetry (DSF) to determine thermal stability (T_m), and chromatography to assess heterogeneity. The outcome is a quantitative profile of the antibody's physical robustness.
Solubility and Chemical Stability Screening	We evaluate the candidate's behavior under various stress conditions. This includes determining its maximum solubility in relevant buffer systems and subjecting it to forced degradation studies (e.g., low/high pH, high temperature, oxidation) to identify key degradation pathways. This provides critical data for future formulation development.
Data Integration and Developability Report	All data from the in silico and experimental stages are integrated into a single, comprehensive report. We provide a clear "developability score" for each candidate, highlighting its specific strengths and weaknesses, and offer recommendation along with strategies for optimization if needed.

Why Choose Us?

Veterinary-Specific Expertise
Our models and assays are informed by deep knowledge of canine and feline immunology and protein behavior. We don't just repurpose human-centric platforms; we build our analysis around the specific needs of your target species, leading to more relevant and predictive results.
Multi-Parameter Approach for a Holistic View
We don't rely on a single data point. Our platform integrates sequence analysis, biophysical characterization, and stability testing to create a complete risk profile. This holistic approach prevents candidates with hidden flaws from advancing, saving you time and resources.
Speed and Clarity
We understand the importance of rapid decision-making in drug development. Our streamlined workflow and clear, concise reporting are designed to deliver actionable insights quickly, enabling your team to make informed go/no-go decisions without delay.

Antibody Optimization. (Creative Biolabs Original)

FAQs

1. How does this service compare to just doing an in silico analysis on our own?

While in silico analysis is a powerful first step, it is predictive, not definitive. Our service provides critical value by validating computational predictions with rigorous, empirical biophysical and chemical stability data. This integration of computational and experimental results provides a much higher degree of confidence in your candidate selection and de-risking strategy.

2. What is the main benefit of performing this assessment so early in the discovery process?

The primary benefit is risk mitigation, which translates directly to cost and time savings. Identifying and fixing a developability issue before you invest in master cell bank generation, process development, and GLP toxicology studies can save hundreds of thousands of dollars and prevent months, or even years, of potential delays.

Related Services

Once you have selected an optimized lead candidate, Creative Biolabs provides a seamless transition to the next stages of development with our integrated suite of preclinical services.

Cell Line Development

We generate high-titer, stable CHO cell lines for the production of your veterinary therapeutic antibody.

Cell Culture Process Development

Our team optimizes upstream processes to maximize yield, quality, and scalability for your specific antibody.

Antibody Purification

We develop robust, scalable downstream purification processes to achieve the high purity required for preclinical and clinical use.

Stability & Formulation Development

We conduct comprehensive studies to define optimal buffer conditions and storage parameters, ensuring long-term product stability.

Non-GMP Production

We offer flexible, non-GMP production runs to generate the material needed for your pivotal preclinical research and toxicology studies.

Partner with Creative Biolabs

Creative Biolabs is your dedicated preclinical CRO partner for veterinary therapeutic antibody development. From initial evaluation and optimization to non-GMP production, our services are designed to de-risk your project, accelerate your timeline, and provide a clear, data-driven path toward the clinic.

Ready to discuss how we can support your project? Our team of veterinary antibody experts is here to help you design the optimal development strategy for your candidate.Ready to discuss your pet therapeutic antibody project? Contact our team for more information and to discuss your antibody developability evaluation and optimization project.

Contact Our Team for More Information and to Discuss Your Project.

Services